Arachchillage Deepa Ranjani Jayakody, Carr Trevor F, Kerr Bronwyn, Hawkins Kay, Kelsey Anna, Judge Mary, Wynn Robert F
Departments of Hematology/Blood & Marrow Transplant, Hope Hospital, Salford, UK.
J Pediatr Hematol Oncol. 2010 Mar;32(2):152-5. doi: 10.1097/MPH.0b013e3181cf4575.
Juvenile xanthogranuloma (JXG) is rarely associated with either hemophagocytic lymphohistiocytosis (HLH) or juvenile myelomonocytic leukemia (JMML) and when in association with the latter there is usually neurofibromatosis type 1. We report a child who presented with JXG and HLH during the neonatal period and who subsequently developed JMML during early infancy in whom there is no evidence of neurofibromatosis type 1. The patient was refractory to standard HLH therapy but he is well and is now 42 months after mismatched unrelated donor hemopoietic stem cell transplant without evidence of HLH or JMML. His JXG lesions show involution, in keeping with the expected natural history of this disorder.
幼年黄色肉芽肿(JXG)很少与噬血细胞性淋巴组织细胞增生症(HLH)或幼年型粒单核细胞白血病(JMML)相关,而当与后者相关时,通常伴有1型神经纤维瘤病。我们报告一名新生儿期出现JXG和HLH且在婴儿早期随后发展为JMML的儿童,该患儿无1型神经纤维瘤病证据。该患者对标准HLH治疗无效,但目前状况良好,在接受不匹配无关供者造血干细胞移植42个月后,无HLH或JMML迹象。他的JXG病变显示消退,符合该疾病预期的自然病程。